Cargando…
Treatment with Venetoclax for Chronic Lymphocytic Leukemia with the Highest Known White Blood Cell Count: Safe and Effective
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Galenos Publishing
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656115/ https://www.ncbi.nlm.nih.gov/pubmed/34792306 http://dx.doi.org/10.4274/tjh.galenos.2021.2021.0435 |
| _version_ | 1784612216009392128 |
|---|---|
| author | Sönmez, Mehmet Kestane, Merve Akıdan, Osman Erkut, Nergiz Bektaş, Özlen |
| author_facet | Sönmez, Mehmet Kestane, Merve Akıdan, Osman Erkut, Nergiz Bektaş, Özlen |
| author_sort | Sönmez, Mehmet |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8656115 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Galenos Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86561152021-12-16 Treatment with Venetoclax for Chronic Lymphocytic Leukemia with the Highest Known White Blood Cell Count: Safe and Effective Sönmez, Mehmet Kestane, Merve Akıdan, Osman Erkut, Nergiz Bektaş, Özlen Turk J Haematol Letters to the Editor Galenos Publishing 2021-12 2021-12-07 /pmc/articles/PMC8656115/ /pubmed/34792306 http://dx.doi.org/10.4274/tjh.galenos.2021.2021.0435 Text en © Copyright 2021 by Turkish Society of Hematology / Turkish Journal of Hematology, Published by Galenos Publishing House. https://creativecommons.org/licenses/by/2.5/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letters to the Editor Sönmez, Mehmet Kestane, Merve Akıdan, Osman Erkut, Nergiz Bektaş, Özlen Treatment with Venetoclax for Chronic Lymphocytic Leukemia with the Highest Known White Blood Cell Count: Safe and Effective |
| title | Treatment with Venetoclax for Chronic Lymphocytic Leukemia with the Highest Known White Blood Cell Count: Safe and Effective |
| title_full | Treatment with Venetoclax for Chronic Lymphocytic Leukemia with the Highest Known White Blood Cell Count: Safe and Effective |
| title_fullStr | Treatment with Venetoclax for Chronic Lymphocytic Leukemia with the Highest Known White Blood Cell Count: Safe and Effective |
| title_full_unstemmed | Treatment with Venetoclax for Chronic Lymphocytic Leukemia with the Highest Known White Blood Cell Count: Safe and Effective |
| title_short | Treatment with Venetoclax for Chronic Lymphocytic Leukemia with the Highest Known White Blood Cell Count: Safe and Effective |
| title_sort | treatment with venetoclax for chronic lymphocytic leukemia with the highest known white blood cell count: safe and effective |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656115/ https://www.ncbi.nlm.nih.gov/pubmed/34792306 http://dx.doi.org/10.4274/tjh.galenos.2021.2021.0435 |
| work_keys_str_mv | AT sonmezmehmet treatmentwithvenetoclaxforchroniclymphocyticleukemiawiththehighestknownwhitebloodcellcountsafeandeffective AT kestanemerve treatmentwithvenetoclaxforchroniclymphocyticleukemiawiththehighestknownwhitebloodcellcountsafeandeffective AT akıdanosman treatmentwithvenetoclaxforchroniclymphocyticleukemiawiththehighestknownwhitebloodcellcountsafeandeffective AT erkutnergiz treatmentwithvenetoclaxforchroniclymphocyticleukemiawiththehighestknownwhitebloodcellcountsafeandeffective AT bektasozlen treatmentwithvenetoclaxforchroniclymphocyticleukemiawiththehighestknownwhitebloodcellcountsafeandeffective |